The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Veillonella


High impact information on Veillonella


Chemical compound and disease context of Veillonella


Biological context of Veillonella


Anatomical context of Veillonella


Gene context of Veillonella


Analytical, diagnostic and therapeutic context of Veillonella


  1. Human complement activation by lipopolysaccharides from bacteroides oralis, fusobacterium nucleatum, and veillonella parvula. Nygren, H., Dahlén, G., Nilsson, L.A. Infect. Immun. (1979) [Pubmed]
  2. In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis. Goldstein, E.J., Citron, D.M., Merriam, C.V., Warren, Y., Tyrrel, K.L., Fernandez, H. Antimicrob. Agents Chemother. (2003) [Pubmed]
  3. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Jorgensen, J.H., Crawford, S.A., Alexander, G.A. Antimicrob. Agents Chemother. (1980) [Pubmed]
  4. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria. Devlin, H.R., Boskovski, L. Drugs (1988) [Pubmed]
  5. Tetracycline resistance and TetM in oral anaerobic bacteria and Neisseria perflava-N. sicca. Roberts, M.C., Moncla, B.J. Antimicrob. Agents Chemother. (1988) [Pubmed]
  6. Sequence of the sodium ion pump methylmalonyl-CoA decarboxylase from Veillonella parvula. Huder, J.B., Dimroth, P. J. Biol. Chem. (1993) [Pubmed]
  7. Acetate kinase from Veillonella alcalescens. Regulation by succinate and substrates. Griffith, M.J., Nishimura, J.S. J. Biol. Chem. (1979) [Pubmed]
  8. nimE gene in a metronidazole-susceptible Veillonella sp. strain. Marchandin, H., Jean-Pierre, H., Campos, J., Dubreuil, L., Teyssier, C., Jumas-Bilak, E. Antimicrob. Agents Chemother. (2004) [Pubmed]
  9. In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections. Wexler, H.M., Molitoris, E., Molitoris, D., Finegold, S.M. Antimicrob. Agents Chemother. (1998) [Pubmed]
  10. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria. Aldridge, K.E. Antimicrob. Agents Chemother. (1994) [Pubmed]
  11. Utilization of fructose and ribose in lipopolysaccharide synthesis by Veillonella parvula. Tortorello, M.L., Delwiche, E.A. Infect. Immun. (1983) [Pubmed]
  12. Bacteriolysis of Veillonella alcalescens by lysozyme and inorganic anions present in saliva. Tortosa, M., Cho, M.I., Wilkens, T.J., Iacono, V.J., Pollock, J.J. Infect. Immun. (1981) [Pubmed]
  13. L-serine enhances the anaerobic lactate metabolism of Veillonella dispar ATCC 17745. Hoshino, E. J. Dent. Res. (1987) [Pubmed]
  14. Nitrite reduction in Veillonella alcalescens. Yordy, D.M., Delwiche, E.A. J. Bacteriol. (1979) [Pubmed]
  15. Putrescine and cadaverine are constituents of peptidoglycan in Veillonella alcalescens and Veillonella parvula. Kamio, Y., Nakamura, K. J. Bacteriol. (1987) [Pubmed]
  16. Stereochemistry of the methylmalonyl-CoA decarboxylation reaction. Hoffmann, A., Dimroth, P. FEBS Lett. (1987) [Pubmed]
  17. Nitrate-reductase electron-transport cofactors in Veillonella alcalescens. Ruoff, K.L., Delwiche, E.A. Can. J. Microbiol. (1977) [Pubmed]
  18. The role of TG lymphocytes in cell-mediated immunity in patients with periodontal disease. Ivanyi, L., Topic, B., Lydyard, P.M. Clin. Exp. Immunol. (1981) [Pubmed]
  19. Impaired bactericidal activity of PMN from two brothers with necrotizing ulcerative gingivo-periodontitis. Cutler, C.W., Wasfy, M.O., Ghaffar, K., Hosni, M., Lloyd, D.R. J. Periodontol. (1994) [Pubmed]
  20. Effect of the interleukin-1 genotype on monocyte IL-1beta expression in subjects with adult periodontitis. Mark, L.L., Haffajee, A.D., Socransky, S.S., Kent, R.L., Guerrero, D., Kornman, K., Newman, M., Stashenko, P. J. Periodont. Res. (2000) [Pubmed]
  21. A comparison of the adhesion, coaggregation and cell-surface hydrophobicity properties of fibrillar and fimbriate strains of Streptococcus salivarius. Handley, P.S., Harty, D.W., Wyatt, J.E., Brown, C.R., Doran, J.P., Gibbs, A.C. J. Gen. Microbiol. (1987) [Pubmed]
  22. Studies by electron-paramagnetic-resonance spectroscopy on the mechanism of action of xanthine dehydrogenase from Veillonella alcalescens. Dalton, H., Lowe, D.J., Pawlik, T., Bray, R.C. Biochem. J. (1976) [Pubmed]
  23. Penicillin-binding proteins involved in high-level piperacillin resistance in Veillonella spp. Theron, M.M., van Rensburg, M.N., Chalkley, L.J. J. Antimicrob. Chemother. (2003) [Pubmed]
  24. Methylmalonyl-CoA decarboxylase from Propionigenium modestum--cloning and sequencing of the structural genes and purification of the enzyme complex. Bott, M., Pfister, K., Burda, P., Kalbermatter, O., Woehlke, G., Dimroth, P. Eur. J. Biochem. (1997) [Pubmed]
  25. Phenotypic differentiation of some of the Veillonella species with the API ZYM system. Kelley, R.W. Can. J. Microbiol. (1982) [Pubmed]
  26. Subgingival microflora of periodontal patients on tetracycline therapy. Williams, B.L., Osterberg, S.K., Jorgensen, J. Journal of clinical periodontology. (1979) [Pubmed]
WikiGenes - Universities